Physician profile
Catherine Chen
NPI 1861653479
$1,782.06
in general payments reported to CMS, 2019-2025
21 companies · $39.81 in 2025
The $39.81 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $274 · 2021: $148 · 2022: $192 · 2023: $42.21 · 2025: $39.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $370.40 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $306.60 | 2019-2021 | |
| Medtronic Vascular, INC. | $163.09 | 2019 | |
| Abbvie INC. | $148.75 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $121.44 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $115.26 | 2019-2020 | |
| Amgen INC. | $84.33 | 2019-2020 | |
| Lilly USA, LLC | $76.90 | 2019-2020 | |
| Genzyme Corporation | $70.52 | 2019-2020 | |
| Arcutis Biotherapeutics, INC. | $42.21 | 2023 | |
| Sanofi Pasteur INC. | $39.81 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.53 | 2019 | |
| Merck Sharp & Dohme LLC | $33.56 | 2019 | |
| Janssen Biotech, INC. | $33.35 | 2019-2020 | |
| Dermira, INC. | $32.85 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $28.76 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $19.05 | 2021 | |
| Galderma Laboratories, L.P. | $18.37 | 2019 | |
| Prugen, INC. Pharmaceuticals | $14.87 | 2019 | |
| Almirall LLC | $14.23 | 2021 | |
| Celgene Corporation | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.